138 related articles for article (PubMed ID: 17067754)
1. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism.
Rybicki BA; Neslund-Dudas C; Nock NL; Schultz LR; Eklund L; Rosbolt J; Bock CH; Monaghan KG
Cancer Detect Prev; 2006; 30(5):412-22. PubMed ID: 17067754
[TBL] [Abstract][Full Text] [Related]
2. Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.
Nock NL; Tang D; Rundle A; Neslund-Dudas C; Savera AT; Bock CH; Monaghan KG; Koprowski A; Mitrache N; Yang JJ; Rybicki BA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1236-45. PubMed ID: 17548691
[TBL] [Abstract][Full Text] [Related]
3. Occupational exposure to polycyclic aromatic hydrocarbons and risk of prostate cancer.
Barul C; Parent ME
Environ Health; 2021 Jun; 20(1):71. PubMed ID: 34154586
[TBL] [Abstract][Full Text] [Related]
4.
Tiongco RE; Cayanan ND; Catacata M; Dominguez MJ
Biomarkers; 2024 May; 29(3):134-142. PubMed ID: 38428950
[TBL] [Abstract][Full Text] [Related]
5. Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.
Neslund-Dudas C; Levin AM; Beebe-Dimmer JL; Bock CH; Nock NL; Rundle A; Jankowski M; Krajenta R; Dou QP; Mitra B; Tang D; Rebbeck TR; Rybicki BA
Cancer Causes Control; 2014 Jul; 25(7):869-79. PubMed ID: 24801046
[TBL] [Abstract][Full Text] [Related]
6. Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY).
Olsson A; Guha N; Bouaoun L; Kromhout H; Peters S; Siemiatycki J; Ho V; Gustavsson P; Boffetta P; Vermeulen R; Behrens T; Brüning T; Kendzia B; Guénel P; Luce D; Karrasch S; Wichmann HE; Consonni D; Landi MT; Caporaso NE; Merletti F; Mirabelli D; Richiardi L; Jöckel KH; Ahrens W; Pohlabeln H; Tardón A; Zaridze D; Field JK; Lissowska J; Świątkowska B; McLaughlin JR; Demers PA; Bencko V; Foretova L; Janout V; Pándics T; Fabianova E; Mates D; Forastiere F; Bueno-de-Mesquita B; Schüz J; Straif K
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1433-1441. PubMed ID: 35437574
[TBL] [Abstract][Full Text] [Related]
7. GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States.
Vidal I; Zheng Q; Hicks JL; Chen J; Platz EA; Trock BJ; Kulac I; Baena-Del Valle JA; Sfanos KS; Ernst S; Jones T; Maynard JP; Glavaris SA; Nelson WG; Yegnasubramanian S; De Marzo AM
PLoS One; 2021; 16(6):e0241934. PubMed ID: 34191807
[TBL] [Abstract][Full Text] [Related]
8. Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.
Neslund-Dudas C; Levin AM; Rundle A; Beebe-Dimmer J; Bock CH; Nock NL; Jankowski M; Datta I; Krajenta R; Dou QP; Mitra B; Tang D; Rybicki BA
Prostate; 2014 May; 74(6):637-46. PubMed ID: 24500903
[TBL] [Abstract][Full Text] [Related]
9. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case-control study in Western Australia.
Fritschi L; Glass DC; Tabrizi JS; Leavy JE; Ambrosini GL
Occup Environ Med; 2007 Jan; 64(1):60-5. PubMed ID: 17018583
[TBL] [Abstract][Full Text] [Related]
10. Occupational Exposures and Lung Cancer Risk-An Analysis of the CARTaGENE Study.
Moayedi-Nia S; Pasquet R; Siemiatycki J; Koushik A; Ho V
J Occup Environ Med; 2022 Apr; 64(4):295-304. PubMed ID: 35019894
[TBL] [Abstract][Full Text] [Related]
11. Risk of Cardiovascular Complications Among Type 2 Diabetes Mellitus Patients with GSTP1 Genetic Polymorphism: A Nested Case-Control Study and Docking Studies.
Sobha SP; Sankar J; Muthusamy K; Kesavarao KE
Biochem Genet; 2024 May; ():. PubMed ID: 38797798
[TBL] [Abstract][Full Text] [Related]
12. Renal cancer risk and occupational exposure to polycyclic aromatic hydrocarbons and plastics.
Karami S; Boffetta P; Brennan P; Stewart PA; Zaridze D; Matveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Gromiec JP; Sobotka R; Chow WH; Rothman N; Moore LE
J Occup Environ Med; 2011 Feb; 53(2):218-23. PubMed ID: 21270648
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer.
Catsburg C; Joshi AD; Corral R; Lewinger JP; Koo J; John EM; Ingles SA; Stern MC
Carcinogenesis; 2012 Jul; 33(7):1352-9. PubMed ID: 22610071
[TBL] [Abstract][Full Text] [Related]
14. Farming and prostate cancer.
Rafnsson V
Occup Environ Med; 2007 Mar; 64(3):143. PubMed ID: 17339294
[TBL] [Abstract][Full Text] [Related]
15. Recreational and occupational physical activity in relation to prostate cancer aggressiveness: the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Steck SE; Su LJ; Antwi SO; Morris BB; Crawford B; Adams SA; Hebert JR; Fontham ETH; Bensen JT; Mohler JL; Arab L
Cancer Causes Control; 2022 Jun; 33(6):875-887. PubMed ID: 35320830
[TBL] [Abstract][Full Text] [Related]
16. Toenail zinc and risk of prostate cancer in the MCC-Spain case-control study.
Gutiérrez-González E; Pastor-Barriuso R; Castelló A; Castaño-Vinyals G; Fernández de Larrea-Baz N; Dierssen-Sotos T; Jiménez-Moleón JJ; Molina-Barceló A; Fernández-Tardón G; Zumel-Marne Á; Moreno V; Gómez-Ariza JL; Sierra MÁ; García-Barrera T; Espinosa A; Plans-Beriso E; Gómez-Acebo I; Aragonés N; Kogevinas M; Pollán M; Pérez-Gómez B
Environ Res; 2024 Mar; 245():118065. PubMed ID: 38159663
[TBL] [Abstract][Full Text] [Related]
17. Cadmium exposure and risk of prostate cancer: a meta-analysis of cohort and case-control studies among the general and occupational populations.
Chen C; Xun P; Nishijo M; Carter S; He K
Sci Rep; 2016 May; 6():25814. PubMed ID: 27174617
[TBL] [Abstract][Full Text] [Related]
18. Does exposure to agricultural chemicals increase the risk of prostate cancer among farmers?
Parent ME; Désy M; Siemiatycki J
Mcgill J Med; 2009 Jan; 12(1):70-7. PubMed ID: 19753293
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic radiation procedures and risk of prostate cancer.
Myles P; Evans S; Lophatananon A; Dimitropoulou P; Easton D; Key T; Pocock R; Dearnaley D; Guy M; Edwards S; O'Brien L; Gehr-Swain B; Hall A; Wilkinson R; Eeles R; Muir K
Br J Cancer; 2008 Jun; 98(11):1852-6. PubMed ID: 18506189
[TBL] [Abstract][Full Text] [Related]
20. The morbidity and mortality of COVID-19 are correlated with the Ile105Val glutathione
Saadat M
Egypt J Med Hum Genet; 2020; 21(1):52. PubMed ID: 38624527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
